Executive Leadership
Dr. Albert Bourla
Chairman and Chief Executive Officer
As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, “Breakthroughs that change patients’ lives,” with a focus on driving the scientific and commercial innovation needed to transform human health.
Under Albert’s leadership, Pfizer is boldly pursuing one of the most ambitious strategies in the biopharmaceutical industry, aiming to redefine what is possible across oncology, internal medicine, inflammation and immunology and vaccines.
Pfizer is at the forefront of reshaping cancer care. With the 2023 acquisition of Seagen, the company continues to advance a robust pipeline poised to deliver multiple breakthroughs by 2030. Pfizer is also building a meaningful presence in obesity and metabolic disease with a highly differentiated portfolio of next-generation treatments following the 2025 acquisition of Metsera. Albert has made artificial intelligence central to how Pfizer discovers, develops and manufactures medicines, believing it will accelerate innovation and fundamentally change what is possible for patients.
Albert became CEO in January 2019 and advanced Pfizer’s transformation into a science-driven company, divesting non-science-based businesses and increasing investment in R&D and technology. He and his leadership team established Pfizer’s Purpose Blueprint, built on four values: Courage, Excellence, Equity and Joy.
The urgency and innovation that defined Pfizer’s response to COVID-19 — delivering a safe and effective vaccine in eight months and the first FDA-authorized oral antiviral treatment — now shape how the company works across its entire portfolio.
Born in Thessaloniki, Greece, to a family of Holocaust survivors, Albert is a Doctor of Veterinary Medicine with a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. During more than 30 years at Pfizer, he held senior positions in five countries before becoming CEO.
Albert is a Genesis Prize Laureate. He has received the American Association for Cancer Research (AACR) Outstanding Achievement Award for Service to Cancer Science and Medicine, the Anti-Defamation League (ADL) Courage Against Hate Award and the Concordia Leadership Award. He was named among Fortune’s Most Powerful People in Business, Time’s 100 Most Influential People in Health and CEO of the Year by CNN Business.
He is Chair of the Pfizer Foundation and Co-Chair of the Partnership for New York City. He previously served as Chair of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as President of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
Albert can be found on X at @AlbertBourla and on LinkedIn.
Other People In Executive Leadership
Executive Leadership
Dr. Albert Bourla
Chairman and Chief Executive Officer
As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, “Breakthroughs that change patients’ lives,” with a focus on driving the scientific and commercial innovation needed to transform human health.
Under Albert’s leadership, Pfizer is boldly pursuing one of the most ambitious strategies in the biopharmaceutical industry, aiming to redefine what is possible across oncology, internal medicine, inflammation and immunology and vaccines.
Pfizer is at the forefront of reshaping cancer care. With the 2023 acquisition of Seagen, the company continues to advance a robust pipeline poised to deliver multiple breakthroughs by 2030. Pfizer is also building a meaningful presence in obesity and metabolic disease with a highly differentiated portfolio of next-generation treatments following the 2025 acquisition of Metsera. Albert has made artificial intelligence central to how Pfizer discovers, develops and manufactures medicines, believing it will accelerate innovation and fundamentally change what is possible for patients.
Albert became CEO in January 2019 and advanced Pfizer’s transformation into a science-driven company, divesting non-science-based businesses and increasing investment in R&D and technology. He and his leadership team established Pfizer’s Purpose Blueprint, built on four values: Courage, Excellence, Equity and Joy.
The urgency and innovation that defined Pfizer’s response to COVID-19 — delivering a safe and effective vaccine in eight months and the first FDA-authorized oral antiviral treatment — now shape how the company works across its entire portfolio.
Born in Thessaloniki, Greece, to a family of Holocaust survivors, Albert is a Doctor of Veterinary Medicine with a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. During more than 30 years at Pfizer, he held senior positions in five countries before becoming CEO.
Albert is a Genesis Prize Laureate. He has received the American Association for Cancer Research (AACR) Outstanding Achievement Award for Service to Cancer Science and Medicine, the Anti-Defamation League (ADL) Courage Against Hate Award and the Concordia Leadership Award. He was named among Fortune’s Most Powerful People in Business, Time’s 100 Most Influential People in Health and CEO of the Year by CNN Business.
He is Chair of the Pfizer Foundation and Co-Chair of the Partnership for New York City. He previously served as Chair of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as President of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
Albert can be found on X at @AlbertBourla and on LinkedIn.
Other People In Executive Leadership